Indian pharmaceutical market (IPM) grew 8.7 percent in March quarter compared to 7.2 percent in the previous quarter indicating recovery. On the flipside –the US business that contributes around 40-50 percent sales of major India drugs makers is expected to remain under pressure without meaningful ...
Read more: Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key